Payload Logo
Pharma

BioAge Labs wants to raise $200 million in IPO to develop obesity and diabetes drugs

By Bruce Gil and Andy Mills
Published

📬 Sign up for the Daily Brief

Our free, fast and fun briefing on the global economy, delivered every weekday morning.